106577
2-Iodohippuric acid
98%
Sinonimo/i:
N-(2-Iodobenzoyl)glycine
Autenticatiper visualizzare i prezzi riservati alla tua organizzazione & contrattuali
Scegli un formato
10 G
59,99 €
59,99 €
Prezzo di listino85,70 €Risparmia il 30%Per informazioni sulla disponibilità, contatta il Servizio Clienti.
Richiedi un ordine bulk
Scegli un formato
Cambia visualizzazione
10 G
59,99 €
About This Item
Formula condensata:
IC6H4CONHCH2CO2H
Numero CAS:
Peso molecolare:
305.07
Beilstein:
1877943
Numero CE:
Numero MDL:
Codice UNSPSC:
12352106
ID PubChem:
NACRES:
NA.22
59,99 €
Prezzo di listino85,70 €Risparmia il 30%Per informazioni sulla disponibilità, contatta il Servizio Clienti.
Richiedi un ordine bulk
Prodotti consigliati
Saggio
98%
Impiego in reazioni chimiche
reaction type: solution phase peptide synthesis
Punto di fusione
170-172 °C (lit.)
Stringa SMILE
OC(=O)CNC(=O)c1ccccc1I
InChI
1S/C9H8INO3/c10-7-4-2-1-3-6(7)9(14)11-5-8(12)13/h1-4H,5H2,(H,11,14)(H,12,13)
CORFWQGVBFFZHF-UHFFFAOYSA-N
Cerchi prodotti simili? Visita Guida al confronto tra prodotti
Codice della classe di stoccaggio
11 - Combustible Solids
Classe di pericolosità dell'acqua (WGK)
WGK 3
Punto d’infiammabilità (°F)
Not applicable
Punto d’infiammabilità (°C)
Not applicable
Dispositivi di protezione individuale
Eyeshields, Gloves, type N95 (US)
Scegli una delle versioni più recenti:
Possiedi già questo prodotto?
I documenti relativi ai prodotti acquistati recentemente sono disponibili nell’Archivio dei documenti.
M Barceló-Oliver et al.
Journal of inorganic biochemistry, 101(4), 649-659 (2007-02-13)
The X-ray structure of the [Cu(I-hip)(phen)2](+).(I-hip-).(H2O)7 complex (1) (where I-hipH is referred to o-iodohippuric acid and phen is 1,10-phenanthroline) and its binary synthetic intermediate [Cu(I-hip)2(H2O)3].(H2O)2 (2) have been solved and characterized by different techniques. This ternary [Cu(I-hip)(phen)2]+.(I-hip-).7H2O complex generates the
Raymond Miralbell et al.
International journal of radiation oncology, biology, physics, 58(3), 809-816 (2004-02-18)
Patients with malignant hematologic disorders undergoing bone marrow transplantation (BMT) may develop renal insufficiency. A study was undertaken to assess prospectively the subclinical renal function changes with radioisotopic methods in patients undergoing BMT for hematologic malignancies. We studied 71 patients
Gopal Pathuri et al.
Nuclear medicine communications, 32(10), 908-912 (2011-08-31)
We recently identified p-[(18)F]fluorohippurate ([(18)F]PFH) as a potential positron emission tomography (PET) renal agent. The objective of this study was to compare renogram parameters of [(18)F]PFH with o-[(125)I]iodohippurate ([(125)I]OIH) as a surrogate for the renal imaging gold standard (131)I-OIH and
Andrew T Taylor et al.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 54(4), 578-584 (2013-02-21)
The pharmacokinetics of the tricarbonyl core radiopharmaceutical (99m)Tc(CO)3-nitrilotriacetic acid ((99m)Tc(CO)3(NTA)) in rats and subjects with normal renal function are comparable to those of (131)I-o-iodohippuran ((131)I-OIH), the radiopharmaceutical gold standard for the measurement of effective renal plasma flow. Our objective was
Andrew T Taylor et al.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 45(5), 885-891 (2004-05-12)
99mTc-Mercaptoacetyltriglycine ((99m)Tc-MAG3) and (99m)Tc-L,L-ethylenedicysteine ((99m)Tc-LL-EC) are useful renal radiopharmaceuticals; however, both agents have renal clearances less than that of (131)I-orthoiodohippurate ((131)I-OIH), and (99m)Tc-LL-EC exists in dianionic and monoanionic forms at physiologic pH. In an effort to develop a superior (99m)Tc
Filtri attivi
Il team dei nostri ricercatori vanta grande esperienza in tutte le aree della ricerca quali Life Science, scienza dei materiali, sintesi chimica, cromatografia, discipline analitiche, ecc..
Contatta l'Assistenza Tecnica.
